1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow VIN, Usual Type: new trials by email Literature Review of VIN, Usual Type trials Research Report on VIN, Usual Type
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) Artesunate ointment, Placebo ointment - Vulvar Diseases, HPV Infection | Phase 2 | Recruiting | Frantz Viral Therapeutics, LLC | 27 | 2023-12-06 | 2025-08-14 |
Papillomavirus Infections (1) · Vulvar Diseases (1)
Communicable Diseases (1) · DNA Virus Infections (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Sexually Transmitted Diseases (1) · Sexually Transmitted Diseases, Viral (1) · Tumor Virus Infections (1) · Urogenital Diseases (1) · Virus Diseases (1)
artemisinin (1) · artenimol (1) · artesunic acid (1)
Frantz Viral Therapeutics, LLC (1)
United States (1)